CASE DISCUSSION
GLP-1 Agonist beyond Diabetes and Weight Control
Presented India by Dr. Dina NagodraViews
47
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
This case-based discussion explores the evolving use of GLP-1 receptor agonists beyond their established roles in diabetes and weight management. Through a clinical case, the session will examine patient assessment, therapeutic decision-making, potential metabolic and cardiovascular benefits, and...
Case Summary
- Incretin-based therapies, including glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists such as semaglutide and tirzepatide, have expanded beyond glycemic control to transform cardiometabolic, hepatic, and renal disease management.
Speaker Profile
Dr. Dina Nagodra
DiabetologyDr. Dina Nagodra Mithani is a Consultant Diabetologist at the Diabetes Endocrine Nutrition Management and Research Centre, Mumbai. She specializes in the clinical management of diabetes and metabolic disorders, with a focus on individualized patient care, diabetes complications, nutrition, and comprehensive metabolic health. Her clinical experience encompasses the practical management of patients with diabetes and related endocrine and metabolic conditions.